Porous silicon for medical use: From conception to clinical use

Porous Silicon for Biomedical Applications

Volumn , Issue , 2014, Pages 3-20

  Canham, L T ^a  

^a Malvern Hills Science Park   (United Kingdom)

Author keywords

Biodegradability; Brachytherapy; Clinical; Medical; Porous silicon

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; BIOLOGICAL MATERIALS; ONCOLOGY; RADIOTHERAPY; SILICON;

BRACHYTHERAPY; CLINICAL; CLINICAL ASSESSMENTS; CLINICAL USE; MEDICAL; MEDICAL USE; NANOSTRUCTURED SILICON; PRE-CLINICAL;

POROUS SILICON;

EID: 84902225182     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857097156.1.3     Document Type: Chapter

References (33)

1. Batchelor L., Loni A., Canham L.T., Hasan M., Coffer J.L. Manufacture of mesoporous silicon from living plants and agricultural waste: an environmentally friendly and scalable process. Silicon 2012, 4(4). 10.1007/s12633-012-9129-8.
2. Bimbo L.M., Sarparanta M., Santos H.A., Airaksinen A.J., Makila E., Laaksonen T., Peltonen L., Lehto V.P., Hirvonen J., Salonen J. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 2010, 4(6):3023-3032.
3. Bowditch A.P., Waters K., Gale H., Rice P., Scott E.A.M., Canham L.T., Reeves C.L., Loni A., Cox T.I. In-vivo assessment of tissue compatibility and calcification of bulk and porous silicon. Materials Research Society Symposium Proceedings 1999, 536:149-154. Implants for administering substances and methods of producing implants. L.T. Canham, C.P. Barrett, A.P. Bowditch, T.I. Cox and P.J.Wright. PCT Patent Application WO 99/53898.
4. Canham L.T., Saunders S.J., Heeley P.B., Keir A.M., Cox T.I. Rapid chemography of porous silicon undergoing hydrolysis. Advanced Materials 1994, 6(11):865-868.
5. Canham L.T. Bioactive silicon fabrication through nanoetching techniques. Advanced Materials 1995, 7:1033-1035.
6. Canham L.T., Reeves C.L. Apatite nucleation on low porosity silicon in acellular simulated body fluids. Thin Films and Surfaces for Bioactivity and Biomedical Applications 1996, 414:189-194. C. Cotell, A.E. Meyer, S.M. Gorbatkin, G.L. Grobe (Eds.).
7. Canham L.T., Reeves C.L., King D.O., Branfield D.L., Crabb J.G., Ward M.C.L. Bioactive polycrystalline silicon. Advanced Materials 1996, 8(10):850-852.
8. Canham L.T., Reeves C.L., Newey J.P., Houlton M.R., Cox T.I., Buriak J.M., Stewart M.P. Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma. Advanced Materials 1999, 11(18):1505-1507.
9. Canham L.T. Biomedical MEMS: Clinical Applications of Silicon Technology 2003, Inst. of Physics Pub. Inc.
10. Canham L.T. Nanoscale semiconducting silicon as a nutritional food additive. Nanotechnology 2007, 18:6. 185704.
11. Cheng L., Anglin E., Cunin F., Kim D., Sailor M.J., Falkenstein I., Tammewar A., Freeman W.R. Intravitreal properties of porous silicon photonic crystals. British Journal of Ophthalmology 2008, 92(5):705-711.
12. Desai T.A., Chu W.H., Ferrari M., Rasi G., Vallebona P., Borboni P., Beattle G., Hayek A. Implantation of microfabricated immuno isolating biocapsules. SPIE Proceedings 1998, 3528:40-47.
13. Desai T.A., Hansford D.J., Kulinsky L., Nashat A.H., Rasi G., Tu J., Wang Y., Zhang M., Ferrari M. Nanopore technology for biomedical applications. Biomedical Microdevices 1999, 2(1):11-40.
14. Edell D.J., van Toi V., McNeil V.M., Clark L.D. Factors influencing the biocompatibility of insertable silicon microshafts in cerebral cortex. IEEE Transactions on Biomedical Engineering 1992, 39:635-643.
15. Einspruch N.G., Gold R.D. VLSI in medicine ; Microstructure Science 1989, Vol. 17. Acadamic Press.
16. Gelloz B., Kojima A., Koshida N. Highly efficient and stable luminescence of nanocrystalline porous silicon treated by high pressure water vapour annealing. Applied Physics Letters 2005, 87(3):031107.
17. Goh A.S., Chung A.Y., Lo R.H., Lau T.N., Yu S.W., Chng M., Satchithanantham S., Loong S.L., Ng D.C., Lim B.C., Connor S., Chow P.K. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorus 32 brachytherapy delivery device - a first in man study. International Journal of Radiation Oncology. Biology. Physics 2007, 67(3):786-792.
18. Grayson A.C.R., Shawgo R.S., Johnson A.M., Flynn N.T., Li Y., Cima M.J., Langer R.L. A BioMEMS review: MEMS technology for physiologically integrated devices. Proceedings of the IEEE 2004, 92(1):6-21.
19. Hermawan H., Mantovani D. Degradable metallic biomaterials: the concept, current developments and future directions. Minerva Biotecnologica 2009, 21:207-216.
20. Hon N.K., Shaposhnik Z., Diebold E.D., Tamanoi F., Jalali B. Tailoring the biodegradability of porous silicon nanoparticles. Journal of Biomedical Materials Research 2012, 100(12):3416-3421.
21. Hwang S.W., Tao H., Kim D.H., Cheng H., Song J.K., Rill E., Brenckle M.A., Panilaitis B., Won S.M., Kim Y.S., Song Y.M., Yu K.J., Ameen A., Li R., Su Y., Yang M., Kaplan D.L., Zakin M.R., Slepian M.J., Huang Y., Omenetto F.G., Rogers J.A. A physically transient form of electronics. Science 2012, 337:1640-1644.
22. IPEC-PMG 2006, http://ec.europa.eu/health/files/counterf_par_trade/doc_publ_consult_200803/111_b_international_pharmaceutical_excipients_council_en.pdf.
23. Jugdaohsingh R. Silicon and bone health. Journal of Nutrition, Health and Aging 2007, 11(2):99-110.
24. Kotzar G., Freas M., Abel P., Fleischman A., Roy S., Zorman C., Moran J.M., Melzak J. Evaluation of MEMS materials of construction for implantable medical devices. Biomaterials 2002, 23:2737-2750.
25. Park J.H., Gu L., Maltzahn G., Ruosiahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in-vivo applications. Nature Materials 2009, 8(4):331-336.
26. Ratner B.D., Hoffman A.S., Schoen F.J., Lemons J.E. Biomaterials Science: An Introduction to Materials in Medicine 2004, 851. Elsevier Inc, San Diego, CA, p. 851. 2nd Edition.
27. Rosengren A., Wallman L., Bengtsson M., Laurell Th., Danielsen N., Bjursten L.M. Tissue reactions to porous silicon: a comparative biomaterial study. Physica Status Solidi (a) 2000, 182:527-531.
28. Ross P.J., Meenan J., Doherty M.O., Calara J., Palmer D.H., Heatley S., Chow P.H. Novel delivery via endoscopic ultrasound of a 32P brachytherapy device in addition to gemcitabine in advanced pancreatic cancer 2008, Abstract No 205. ASCO Gastronintestinal Cancers Symposium January 26, Orlando, FL, USA.
29. Schmidt S., Horch K., Normann R. Biocompatibility of silicon-based electrode arrays implanted in feline cortical tissue. Journal of Biomedical Materials Research 1993, 27(11):1393-1399.
30. Shabir Q., Pokale A., Loni A., Johnson D.R., Canham L.T., Fenollosa R., Tymczenko M., Rodriguez I., Meseguer F., Cros A., Cantarero A. Medically biodegradable hydrogenated amorphous silicon microspheres. Silicon 2011, 10.1007/s12633-011-9097-4.
31. Shabir Q., Skaria C., Brien H.O., Loni A., Barnett C., Canham L. Taste and mouthfeel assessment of porous and non-porous silicon microparticles. Nanoscale Research Letters 2012, 7:407. 10.1186/1556-276X-7-407.
32. Tanaka T., Godin B., Bhavane R., Nievens-Alicea R., Gu J., Liu X., Chiappini C., Fakhoury J.R., Amra S., Ewing A., Li Q., Fidler I.J., Ferrari M. In-vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice. International Journal of Pharmaceutics 2010, 402:190-197.
33. Zhang K., Loong S.L.E., Connor S., Yu S.W.K., Tan S.Y., Ng R.T.H., Lee K.M., Canham L., Chow P.K.H. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic xenografts in nude mice. Clinical Cancer Research 2005, 11(20):7532-7537.